Ocular Hypertension Completed Phase 2 Trials for Bimatoprost (DB00905)

Also known as: Intraocular pressure raised / Ocular Hypertension (OHT) / Hypertension Ocular / Hypertension, Ocular / Intraocular pressure high / Intraocular hypertension / Ocular Hypertension (OH) / Elevated intraoccular pressure / Intraocular pressure increased / IOP increased / Raised IOP / Ocular tension increased / Tension ocular increased / Pressure intraocular increased / Increased intraocular pressure

IndicationStatusPhase
DBCOND0074237 (Ocular Hypertension)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02537015An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular InsertTreatment
NCT02143843An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 ProductTreatment
NCT01915940Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular HypertensionTreatment
NCT02358369Dose-Ranging Study of the Bimatoprost Ocular InsertTreatment
NCT00651859Safety and Efficacy Study of Bimatoprost in Ethnically Japanese Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01110499Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionTreatment
NCT01001195Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic SolutionTreatment
NCT01016691Safety and Efficacy of a Drug Delivery System in GlaucomaTreatment
NCT01291108Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular HypertensionTreatment
NCT01863953A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular HypertensionTreatment
NCT00652496Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular HypertensionTreatment